Literature DB >> 14727060

A fission yeast strain expressing human CDC25A phosphatase: a tool for selectivity studies of pharmacological inhibitors of CDC25.

Odile Mondesert1, Matthieu Lemaire, Marie-Christine Brezak, Marie Odile Galera-Contour, Grégoire Prevost, Bernard Ducommun, Béatrix Bugler.   

Abstract

Fission yeast is a simple eukaryotic model organism in which many aspects of cell cycle control can be explored. We examined by homologous recombination whether the human CDC25A phosphatase could substitute for the function of the fission yeast Cdc25. We first show: (a). that CDC25A efficiently replaces the endogenous Cdc25 mitotic inducer for vegetative growth and (b). that CDC25A is able to partially restore a functional checkpoint in response to both ionising and UV irradiation, but not a DNA replication checkpoint. We then describe a simple assay in which we demonstrate that growth of the humanised CDC25A strain is strongly repressed in a CDC25-dependent manner by BN2003, a potent chemical inhibitor of CDC25 belonging to the benzothiazoledione family. The ease of manipulation of fission yeast humanised CDC25 cells and the simplicity of the above assay offer a powerful tool with which to investigate the specificity of pharmacological inhibitors of CDC25.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14727060     DOI: 10.1007/s00294-003-0483-3

Source DB:  PubMed          Journal:  Curr Genet        ISSN: 0172-8083            Impact factor:   3.886


  19 in total

1.  The Nobel Prize and beyond: an interview with Sir Paul Nurse. Interview by Susan R. Owens.

Authors:  Paul Nurse
Journal:  EMBO Rep       Date:  2002-03       Impact factor: 8.807

2.  Yeast as a host to screen for modulators and regulatory regions of mammalian protein kinase C isoforms.

Authors:  Amadeo M Parissenti; Heimo Riedel
Journal:  Methods Mol Biol       Date:  2003

3.  Nuclear exclusion of Cdc25 is not required for the DNA damage checkpoint in fission yeast.

Authors:  A Lopez-Girona; J Kanoh; P Russell
Journal:  Curr Biol       Date:  2001-01-09       Impact factor: 10.834

Review 4.  The expression of recombinant proteins in yeasts.

Authors:  P E Sudbery
Journal:  Curr Opin Biotechnol       Date:  1996-10       Impact factor: 9.740

5.  Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1.

Authors:  Y Zeng; K C Forbes; Z Wu; S Moreno; H Piwnica-Worms; T Enoch
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

6.  Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein.

Authors:  A Lopez-Girona; B Furnari; O Mondesert; P Russell
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

7.  Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cds1 and Chk1.

Authors:  B Furnari; A Blasina; M N Boddy; C H McGowan; P Russell
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

Review 8.  1,3-beta-Glucan synthase: a useful target for antifungal drugs.

Authors:  J Liu; M K Balasubramanian
Journal:  Curr Drug Targets Infect Disord       Date:  2001-08

9.  A functional screen in yeast for regulators and antagonizers of heterologous protein tyrosine kinases.

Authors:  G Superti-Furga; K Jönsson; S A Courtneidge
Journal:  Nat Biotechnol       Date:  1996-05       Impact factor: 54.908

10.  Protein kinase CK2 regulates CDC25B phosphatase activity.

Authors:  Nathalie Theis-Febvre; Odile Filhol; Carine Froment; Martine Cazales; Claude Cochet; Bernard Monsarrat; Bernard Ducommun; Véronique Baldin
Journal:  Oncogene       Date:  2003-01-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.